SPECIAL FORMULA 17900 FORTE-V LACTATING INTRAMAMMARY ANTIBIOTIC SUSPENSION

Երկիր: Ավստրալիա

Լեզու: անգլերեն

Աղբյուրը: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ակտիվ բաղադրիչ:

NEOMYCIN SULFATE; NOVOBIOCIN AS NOVOBIOCIN SODIUM; DIHYDROSTREPTOMYCIN

Հասանելի է:

ZOETIS AUSTRALIA PTY LTD

INN (Միջազգային անվանումը):

neomycin as sulfate(10.5mg/mL)+novobiocin as Na salt(10mg/mL) + others

Դեղագործական ձեւ:

MISC. INTRA MAMMARY

Կազմը:

NEOMYCIN SULFATE ANTIBIOTIC Active 150.0 mg/10ml; NOVOBIOCIN AS NOVOBIOCIN SODIUM ANTIBIOTIC Active 100.0 mg/10ml; DIHYDROSTREPTOMYCIN ANTIBIOTIC Active 100.0 mg/10ml

Միավորները փաթեթում:

20 x 10mL; plastets

Դաս:

VM - Veterinary Medicine

Պատրաստված է:

ZOETIS AUSTRALIA

Թերապեւտիկ խումբ:

DAIRY CATTLE LACTATING | BOVINE | MILKING COW

Թերապեւտիկ տարածք:

ANTIBIOTIC & RELATED

Թերապեւտիկ ցուցումներ:

MASTITIS | SUBCLINICAL MASTITIS

Ապրանքի ամփոփագիր:

Poison schedule: 4; Withholding period: WHP: Do not use less than 30 days befor e slaughter for human consumption. Mil k collected from cows within 72 hours ( 6 milkings) following treatment must no t be used for human consumption or pro cessing. This milk should not be fed t o bobby calves.; Host/pest details: DAIRY CATTLE LACTATING: [MASTITIS]; For the treatment of bovine mastitis, in lactating dairy cattle only by intramammary infusion..Milk from treated cows should not be fed to bobby calves (See WITHHOLDING PERIODS statement on label).

Լիազորման կարգավիճակը:

Registered

Հաստատման ամսաթիվը:

2023-07-01

Տեղեկատվական թերթիկ

Veterinary Labelling
Special Formula 17900 Forte V
Lactating
lntramammary
Antibiotic
Suspension
LABEL
TEXT-
PLASTET SYRINGE
Main Panel
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH
OF
CHILDREN
FOR ANIMAL TREATMENT ONLY
Special
Formula
17900 Forte-V
Lactating
lntramammary
Antibiotic
Suspension
Each 1
Oml PLASTET"' contains
NEOMYCIN
(as neomycin sulphate)
NOVOBIOCIN
105mg
100mg
(as novobiocin sodium)
DIHYDROSTREPTOMYCIN
(as the sulphate)
100mg
For the treatment
of
bovine mastitis.
1
Oml PLASTET'" Disposable Syringe
Store
below
25°C (Air-
conditioning)
Batch:
Expiry:
Right Hand Side Panel
READ
THE
CARTON BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE
SHAKE WELL BEFORE USE
Infuse one PLASTEr'"
(10ml)
per infected quarter.
WITHHOLDING PERIODS
DO NOT
USE
less
than
30
days before
slaughter
for
human
consumption.
APVMA Page 1
of
4
15
1
h
July 2013
+
RLP
Approved
Milk
collected
from
cows
within
72
hours
(6
milkings)
following
treatment
MUST NOT BE
USED
for
human
consumption
or
processing.
This
milk
should
not
be
fed
to
bobby
calves.
APVMA Approval
No.
38696
I
60502
Zoetis Australia Pty
Ltd
38-42 Wharf Road
West Ryde, NSW 2114
LABEL
Veterinary Labelling
SPECIAL FORMULA 17900 FORTE-V
LACTATING LNTRAMAMMARY ANTIBIOTIC SUSPENSION
Main Panel
PRESCRIPTION ANIMAL REMEDY
KEEP
OUT
OF
REACH OF CHILDREN
FOR ANIMAL TREATMENT
ONLY
SPECIAL FORMULA
17900 FORTE-V
CARTON TEXT
LACTATING LNTRAMAMMARY ANTIBIOTIC SUSPENSION
Each 1
OmL
PLASTETN contains
NEOMYCIN
(as neomycin sulphate)
NOVOBIOCIN
(as novobiocin sodium)
DIHYDROSTREPTOMYCIN
(as the sulphate)
APVMA Page 2
of
4
15
July
2013
105MG
100MG
100MG
For the treatment
of
bovine mastitis,
in
lactating cattle only,
by
intramammary infusion.
20 x 1
OmL
PLASTET'" Disposable Syringes
[Zoetis logo]
Right Hand Side Panel
DIRECTIONS FOR USE
DOSAGE:
SHAKE
WELL
BEFORE USE
Infuse one PLASTET'"
(1
OmL)
per infected quarter.
One 1
OmL
infusion
of
Special Formula 17900 Forte-V into the affected quarter generally will
be
sufficient.
Repeat treatments at
24
or
48
hour intervals, if necessary.
1.Milk the udde

Ապրանքի հատկությունները

PRODUCT NAME: SPECIAL FORMULA 17900 FORTE-V
®

PAGE: 1 OF 4 
THIS REVISION ISSUED: NOVEMBER 2010 
MATERIAL SAFETY DATA SHEET 
Issued by: Pfizer Australia Pty Ltd 
Phone: [phone]

SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY  

Pfizer Australia Pty Ltd 

 38-42  Wharf  Road 

 West Ryde  NSW  2114 

 Tel:     [phone] 

 Fax:    [phone] 

____________________________________ 

PFIZER AUSTRALIA PTY LTD

A.B.N. 50 008 422 348 
SUBSTANCE:  
Active ingredients are antibiotics.

TRADE NAME:  
SPECIAL FORMULA 17900 FORTE-V
®

PFIZER MSDS CODE: 
101

PRODUCT USE:  
For the treatment of bovine mastitis in lactating cattle only, by
mammary infusion.

CREATION DATE: 
MARCH, 2005 
THIS VERSION ISSUED: 
NOVEMBER, 2010 and is valid for 5 years from this date. 
SECTION 2 - HAZARDS IDENTIFICATION 
STATEMENT OF HAZARDOUS NATURE  
This product is classified as: Not classified as hazardous
according to the criteria of SWA Australia.  
Not a Dangerous Good according to the Australian Dangerous Goods
(ADG) Code.

RISK PHRASES: Not Hazardous - No criteria found. 
SAFETY PHRASES: Not Hazardous - No criteria found. 
SUSDP CLASSIFICATION: S4 
ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the
ADG Code. 
UN NUMBER: None allocated 
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y

O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W

PHYSICAL DESCRIPTION & COLOUR: A pale yellow oily suspension. 
ODOUR: No data. 
MAJOR HEALTH HAZARDS: no significant risk factors have been found for
this product. 
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L

H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H

E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S

Possible effects of overexposure to antibiotics in the workplace
include: symptoms of hypersensitivity (such as skin 
rash, hives, itching, and difficulty breathing); nausea; vomiting;
diarrhoea. 
INHALATION 
SHO